CA-ORAYA-THERAPEUTICS
Oraya Therapeutics announced today that the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists have issued a joint opinion on the adjunctive use of radiotherapy with the IRay® Stereotactic Radiotherapy System for neovascular age-related macular degeneration. The opinion provides guidance for selecting and treating patients with radiotherapy adjunctive to anti-vascular endothelial growth factor (anti-VEGF) therapy in the treatment of wet AMD.
“The joint opinion now provides guidance for ophthalmologists throughout Germany to identify those patients who can benefit from Oraya Therapy for wet AMD. There is a large patient population that does not respond well to anti-VEGF monotherapy, and our aim is to offer these patients in Germany an additional option to maintain their vision and also decrease the burden of frequent injections," said Oraya Therapeutics CEO Jim Taylor. "We are well positioned with our IRay system at major university eye clinics in Germany, and will continue to expand our presence to make the therapy available to the patients who qualify and elect to pursue this alternative.”
The full opinion, titled “Stellungnahme von DOG, RG und BVA zur Strahlentherapie bei neovaskulärer altersabhängiger Makuladegeneration“ is accessible within the German Ophthalmological Society website at http://www.dog.org/wp-content/uploads/2015/10/Stellungnahme-RG-DOG-BVA-zur-Strahlentherapie-bei-neovaskul%C3%A4rer-altersabh%C3%A4ngiger-Makuladegeneration.pdf .
More than 550 patients have been treated with Oraya Therapy in three European countries, including Germany, Switzerland and the United Kingdom.
The IRay Radiotherapy system is a CE marked medical device. In the U.S., the IRay system is an investigational device and is not available for sale.
About the INTREPID Study
The INTREPID study was the first to evaluate the safety and efficacy of Oraya Therapy in conjunction with as-needed anti-VEGF injections for patients with Wet AMD, and is the only sham-controlled double-masked trial to assess stereotactic radiotherapy for Wet AMD. The study met primary and secondary endpoints and showed that Oraya Therapy significantly reduces the need for anti-VEGF injections while maintaining vision in the presence of a favorable safety profile. A total of 21 sites in five European countries participated in the trial. Two-year results showed that a broadly inclusive cohort of previously treated Wet AMD patients continued to receive the benefits of a 25 percent mean reduction in anti-VEGF injections over two years. Additionally, the targeted patient population maintained an impressive 45 percent mean reduction in injections through two-year visit, with stable vision.
About Wet AMD
Wet AMD is characterized by abnormal growth of blood vessels in the macula, and is responsible for the vast majority of severe vision loss in the industrialized world. If left untreated, it can lead to the rapid deterioration of visual acuity and blindness. While there is no cure for wet AMD, the expense and burden of current treatment methods have driven the development and commercialization of novel approaches such as the Oraya Therapy.
About Oraya Therapeutics
About Oraya Therapeutics Oraya Therapeutics, Inc. is a privately held company developing innovative and non-invasive therapies for diseases of the eye, including Oraya Therapy for wet age-related macular degeneration. Oraya Therapy is commercially available in the United Kingdom, Germany and Switzerland. Oraya Therapeutics was founded in 2007. Its investors include Essex Woodlands Health Ventures, Domain Associates, and Scale Venture Partners.
For further information on Oraya Therapeutics, go to www.orayainc.com .
View source version on businesswire.com: http://www.businesswire.com/news/home/20151020005353/en/
Contact:
U.S. Media Contact:
Racepoint Global for Oraya
Susan
Thomas, 415-694-6728
sthomas@racepointglobal.com
or
UK
and Europe Media Contact:
Racepoint Global for Oraya
Ann-Marie
Gannon, + 44 (0) 20 8811 2474
+44 (0) 79 4472 3705 (M)
annmarie.gannon@racepointglobal.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lattice and Mitsubishi Electric Collaborate to Deliver Next-Gen Industrial Automation Experiences17.7.2025 08:30:00 CEST | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced its low power Lattice CertusPro™-NX FPGAs now enable Mitsubishi Electric’s Computerized Numerical Controller (CNC) solutions to bring power efficient and reliable factory automation experiences. This collaboration was announced at the Lattice APAC Tech Summit in Tokyo, where Mitsubishi Electric participated as a guest keynote speaker. Hosted today, Lattice APAC Tech Summit showcased the company’s latest low power FPGA technology with industry leaders including Mitsubishi Electric, Desay, Furukawa AS, Glory LTD, LIPS, and NXP alongside more than 150 customers and partners in the APAC region. Mitsubishi Electric’s industry-leading CNC solutions leverage the cutting-edge interface bridging capabilities of Lattice CertusPro-NX FPGAs to create high accuracy, adaptability, and efficient real-time processing. These features are ideal for a variety of Industrial applications, including machine building, Au
SES Completes Acquisition of Intelsat, Creating Global Multi-Orbit Connectivity Powerhouse17.7.2025 07:30:00 CEST | Press release
New leading multi-orbit space company with a network of 120 GEO+MEO satellites and access to LEO constellations enables SES to better serve its customers SES, a leading space solutions company, today announced the completion of its highly value accretive acquisition of Intelsat, creating a strengthened global satellite operator with an expanded fleet of 120 satellites across two orbits. The newly combined company will leverage its skilled teams with deep vertical expertise to deliver integrated multi-orbit, multi-band satellite and connectivity solutions to businesses and governments around the world, creating a stronger multi-orbit operator with ~60% of revenue in high-growth segments. With a world-class network including approximately 90 geostationary (GEO), nearly 30 medium earth orbit (MEO) satellites, strategic access to low earth orbit (LEO) satellites, and an extensive ground network, SES can now deliver connectivity solutions utilising complementary spectrum bands including C-,
Galderma Unveils Final Nine-Month Data Showing Lasting Efficacy and Patient Satisfaction With Its Injectable Aesthetics Portfolio When Addressing Facial Aesthetic Changes After Medication-Driven Weight Loss17.7.2025 07:00:00 CEST | Press release
Final data from a first-of-its-kind clinical trial confirm that the combination of Sculptra® and Restylane® Lyft™ or Contour™* delivers sustained improvement in facial aesthetic appearance for patients experiencing facial volume loss due to medication-driven weight loss1 Following interim analysis at three months presented earlier this year, a six-month extension study was conducted to capture the durability of treatment effects after nine months1 Galderma continues to lead the response to addressing the aesthetic concerns of patients experiencing medication-driven weight loss, leveraging its deep dermatological expertise and working closely with healthcare professionals to meet evolving patient needs Galderma has revealed positive final data from a phase IV first-of-its-kind trial exploring the benefits of Restylane Lyft or Contour in combination with Sculptrato address the aesthetic concerns of patients experiencing facial volume loss associated with medication-driven weight loss.1 T
Global New Material International: Driving a Green Future Through Innovation17.7.2025 04:41:00 CEST | Press release
As global economic integration accelerates, materials science—the foundation of modern industry—is undergoing a profound transformation. Global New Material International Holdings Limited (GNMI) stands at the forefront of this evolution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716430383/en/ Colored Building-Integrated Photovoltaic modules developed by CQV, a subsidiary of GNMI. At the recent 2nd Sino-European Corporate ESG Best Practice Conference, GNMI was honored with the “Best Practice in Technological Innovation” award for its outstanding commitment to innovation and green development. The judging panel praised the company’s achievements, noting that “GNMI’s innovations have gained broad international recognition. With a clear strategy focused on green manufacturing and sustainability, the company offers viable solutions to reduce dependence on non-renewable resources while advancing eco-friendly production.” T
Andersen Consulting styrker sin platform med tilføjelsen af Baufest16.7.2025 20:07:00 CEST | Pressemeddelelse
Andersen Consulting udvider sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Baufest, et globalt firma inden for digitalt produktdesign og -udvikling. Med mere end 30 års erfaring og kontorer i hele Amerika og Europa er Baufest anerkendt for at kombinere banebrydende teknologi med en dybdegående forståelse af forretningsstrategi og brugeroplevelse. Firmaet tilbyder et omfattende udvalg af tjenester, der omfatter forretningsdesign, udvikling af digitale produkter, data og anvendt AI og cybersikkerhed. Baufest betjener virksomhedskunder på tværs af nøgleindustrier som bank og finans, detailhandel, energi og sundhedspleje med fokus på at skabe målbare forretningsresultater gennem smidig, skalerbar og etisk teknologipraksis. "Vores samarbejde med Andersen Consulting er et vigtigt skridt fremad for de tjenester, vi tilbyder," siger Ángel Pérez Puletti, administrerende direktør for Baufest. "Andersens fulde pakke af specialiserede tjenester bygger på Baufests
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom